Earnings Per Share (adj.)
$0.06
estimate N/A
Revenue
$46.4M
estimate N/A
Stock Price
$1.79
change N/A
What to Watch: The fiscal 2026 revenue guidance of $190 million sets a low bar—watch whether Biote can stabilize profitability as it scales toward that target. The next catalyst is Q1 fiscal 2026 results, expected in early June, where investors will look for evidence that the margin compression has bottomed. With the stock trading near its 52-week low of $1.68 and a market cap of just $81.3 million, any sign of operating leverage returning could trigger a sharp revaluation.
This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.